Literature DB >> 1865222

Isolated and combined pareses of cranial nerves III, IV and VI. A retrospective study of 412 patients.

P Berlit1.   

Abstract

We evaluated the hospital records of 412 patients with isolated or combined ocular nerve palsies in a retrospective study. Palsies of the oculomotor nerve (n = 172) and of the abducens nerve (n = 165) were more frequent than those of the trochlear nerve (n = 25). Combined ocular nerve palsies (n = 50) were generally combinations of the 3rd and 6th cranial nerves (n = 21) or pareses of all three ocular nerves (n = 17). 165 ocular nerve palsies were due to vascular causes: in 135 of these cases diabetes mellitus and hypertension were present. The oculomotor nerve was most frequently affected; in 63% there was no involvement of the pupil. In inflammatory disease and brain tumor the abducens nerve was most frequently affected, with aneurysm of the oculomotor nerve. The origin of ophthalmoplegia was unclear in 73 patients. Ocular nerve paralysis was most common with tumors, aneurysm, and vascular processes and in 206 cases was only partial. Pain was associated with tumor, trauma and aneurysm. In trochlear nerve palsies concomitant pain was much less frequent than in palsies of the other two ocular nerves. The clinical course was followed for 3 weeks in 352 patients; in 191 patients there was a complete regression of the pareses and in 59 only a partial recovery. The most favorable prognosis was with inflammatory and vascular lesions; in the latter the outcome was improved by the administration of non-steroidal anti-inflammatory drugs.

Entities:  

Mesh:

Year:  1991        PMID: 1865222     DOI: 10.1016/0022-510x(91)90276-d

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  19 in total

1.  Isolated oculomotor nerve palsy: an unusual presentation of glioblastoma multiforme. Case report and review of the literature.

Authors:  M al-Yamany; A al-Shayji; M Bernstein
Journal:  J Neurooncol       Date:  1999-01       Impact factor: 4.130

Review 2.  Neuro-Ophthalmological Emergencies.

Authors:  João Lemos; Eric Eggenberger
Journal:  Neurohospitalist       Date:  2015-10

3.  Monocular ophthalmoplegia and partial supranuclear vertical gaze palsy due to unilateral paramedian rostral midbrain infarction.

Authors:  Matthew J Thurtell; R John Leigh; G Michael Halmagyi
Journal:  J Neurol       Date:  2009-04-27       Impact factor: 4.849

4.  Incidence, types, and lifetime risk of adult-onset strabismus.

Authors:  Jennifer M Martinez-Thompson; Nancy N Diehl; Jonathan M Holmes; Brian G Mohney
Journal:  Ophthalmology       Date:  2013-12-08       Impact factor: 12.079

5.  Clinical characteristics and associated comorbidities in diabetic patients with cranial nerve palsies.

Authors:  D Greco; F Gambina; M Pisciotta; M Abrignani; F Maggio
Journal:  J Endocrinol Invest       Date:  2011-03-07       Impact factor: 4.256

Review 6.  Ocular myasthenia gravis. A critical review of clinical and pathophysiological aspects.

Authors:  N Sommer; A Melms; M Weller; J Dichgans
Journal:  Doc Ophthalmol       Date:  1993       Impact factor: 2.379

7.  Prevalence and clinical characteristics of blepharoptosis in patients with diabetes in the Korea National Health and Nutrition Examination Survey (KNHANES) 2009-2010.

Authors:  Seong-Su Moon; Young-Sil Lee
Journal:  Endocrine       Date:  2014-05-17       Impact factor: 3.633

8.  Causes and Outcomes of Patients Presenting with Diplopia: A Hospital-based Study.

Authors:  Nitin Kumar; Savleen Kaur; Srishti Raj; Vivek Lal; Jaspreet Sukhija
Journal:  Neuroophthalmology       Date:  2021-03-02

9.  Delayed cranial nerve palsy after microvascular decompression for hemifacial spasm.

Authors:  Jae-Suk Han; Jeong-Ah Lee; Doo-Sik Kong; Kwan Park
Journal:  J Korean Neurosurg Soc       Date:  2012-10-22

10.  Tolosa-Hunt syndrome masquerading as a carotid artery dissection.

Authors:  Elise J Taylor; Ursula M Anders; Joseph R Martel; James B Martel
Journal:  Clin Ophthalmol       Date:  2014-04-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.